Introduction
Ig CSR allows the recombined variable region gene segment (VDJ) to be expressed with a new downstream C H gene. Classswitching is effected by deletional recombination between S-region sequences located upstream of each of the C H genes, except for C␦. It is generally accepted that CSR requires GL transcription through target S regions [1] and expression of AID [2, 3] . CSR is directed to a particular C H gene by cytokines that induce transcription from GL C H genes before switch recombination to the same C H gene [1, 4] .
IgA is the predominant Ig isotype in mucosal secretions and serves as a first line of defense in the mucosa by inhibiting pathogen adhesion. TGF-␤1 induces GL␣ and GL␥2b transcription and subsequent CSR to IgA and IgG2b [5, 6] . Similarly, TGF-␤1 also directs GL␣1 and GL␣2 transcription and subsequent IgA1 and IgA2 secretion in human B cells [7] . Despite the fact that TGF-␤1 also induces IgG2b CSR, TGF-␤1 is considered a physiological mediator of IgA CSR, as it enhances IgA isotype switching at the clonal level [8] and as deletion of the TGF-␤ or TGF-␤R type II genes results in severe loss of IgA expression [9, 10] . Given that TGF-␤ is the major isotype-switching factor in GALT, it raises the question of why IgA but not IgG2b is the prevailing CSR in GALT, such as PP, resulting in predominantly IgA secretion in the gut. To address this, we have demonstrated that IL-21 inhibits the TGF-␤1-induced IgG2b production in PP [11] . Subsequently, it has been shown that IL-21 can be derived from PP follicular Th cells [12] . Although these observations appear to explain the mechanisms underlying the predominate gut IgA response, the involvement of factors other than TGF-␤1 and IL-21 in this phenomenon has not been explored thoroughly.
RA, a vitamin A metabolite, plays an important role in the regulation of mucosal immunity. RA is synthesized from its precursor molecules, such as retinol in GALT DCs [13] . GALT-DC-derived RA enhances the expression of gut-homing receptors, such as integrin ␣4␤7 and CCR9 on T and B cells [13, 14] . RA also acts as a key regulator of TGF-␤-dependent Th cell differentiation, capable of promoting anti-inflammatory Foxp3 ϩ Treg differentiation [15] [16] [17] and inhibiting the IL-6-driven induction of proinflammatory Th17 cells [18] . Re-lated to the IgA response, VAD is associated with impaired mucosal immunity as a result of selective loss of IgA-producing cells [14] . It has been shown that RA enhances IgA production by LPS-stimulated mouse B cells [19] and that this activity of RA is dependent on IL-5 [20] . GALT-DC-derived RA alone does not promote IgA secretion, but with IL-6 or IL-5, induces IgA expression in B cells [14] . We have recently demonstrated that RA induces GL␣ transcription, primarily through the RAR pathway [21] . Although these results indicate that RA positively regulates the IgA response, it is not still clear whether RA alone acts as a specific IgA isotype-switch factor. In this study, we investigated the precise role of RA and TGF-␤1 in IgA isotype expression by mouse B cells. We found that RA alone induced only IgA isotype expression but not IgG2b in vitro and in vivo. The same was true for the expression of Ig GL transcripts. Furthermore, limiting dilution analysis was used to demonstrate at the clonal level that RA had significant activity as an IgA isotype-switch factor. Together, these results suggest that RA is more specific than TGF-␤1 in IgA CSR. However, the combination of RA and TGF-␤1 further enhanced the expression of IgA antibody, IgA B cell guthoming receptors, CCR9, and ␣4␤7.
MATERIALS AND METHODS

Mice
BALB/c mice were purchased from the Daehan Biolink (Seoul, Korea). Animals were fed Purina Laboratory Rodent Chow 5001 ad libitum. Animal care was performed in accordance with the institutional guidelines set forth by Kangwon National University.
To produce VAD or vitamin A-sufficient mice, pregnant BALB/c mice received a chemically defined diet that lacked vitamin A (AIN-93M feed; Oriental Yeast, Tokyo, Japan) or a regular diet containing retinyl acetate (25,000 IU/kg in the AIN-93M). These diets started at 7-10 days of gestation. The pups were weaned at 3 weeks of age and maintained on the same diet until more than 12 weeks of age, as reported previously [13] .
B cell preparations and cell culture
Murine spleen B cell suspensions were prepared as described previously [22] . Briefly, T cells were depleted from the cell suspensions by treatment with a cocktail of anti-Thy1.2, anti-Lyt2.2, and anti-L3T4 mAb and low-tox rabbit complement (Cedarlane, Ontario, Canada). This resulted in B cells comprising Ͼ90% of the residual population, as assessed by sIg using flow cytometry. Subsequently, sIgA Ϫ B cells were prepared by using anti-mouse
IgA antibody-coated Petri-dish panning. This procedure resulted in Ͼ95% depletion of sIgA ϩ cells.
PP cells were prepared as described previously [23, 24] . Aseptically removed PPs were vigorously washed in RPMI 1640, supplemented with protease (Sigma-Aldrich, St. Louis, MO, USA) and DNase (Promega, Madison, WI, USA) for 30 min at 37°C. The medium containing dissociated cells was collected, and fresh enzyme solution was added immediately to the remaining tissue, which was incubated again for 30 min and repeated four times.
MLN cells were separated from intestinal fatty tissues by using two forceps in a Petri dish containing PBS. MLN cells were teased and harvested by centrifugation at 500 g for 5 min.
A total of 2 ϫ 10 5 cells/well was cultured in flat-bottomed, 96-well tissueculture plates (SPL Life Sciences, Seoul, Korea) in a volume of 200 l complete medium with added LPS (12.5 g/ml; Escherichia coli 0127:B8; SigmaAldrich) in the presence or absence of RA (Sigma-Aldrich), TGF-␤1 (R&D Systems, Minneapolis, MN, USA), anti-pan TGF-␤ antibody (R&D Systems), LE540 (Wako Pure Chemical Industries, Osaka, Japan), and/or AM80 (Tocris Bioscience, Bristol, UK).
Isotype-specific ELISA and ELISPOT assay
ELISAs were performed as described previously [25] . The reaction products were measured at 405 nm with an ELISA reader (VersaMax reader, Molecular Devices, Sunnyvale, CA, USA). For the detection of antibody retained in the gut, fecal pellets were diluted in PBS and centrifuged at 10,000 g for 10 min, and supernatants were collected.
An isotype-specific ELISPOT assay was performed as described previously [8] . Data are presented as numbers of spot-forming cells/2 ϫ 10 5 cultured cells with background subtracted.
Limiting dilution analysis
For limiting dilution analysis, sIgA Ϫ spleen B cells were cultured at various cell densities in round-bottomed, 96-well plates in a final volume of 200 l complete medium. A total of 96 replicate cultures was set up at each cell density. Cultured wells were assayed individually for numbers of IgAsecreting cells by ELISPOT assay after 6 days of culture. Cultures with spot-forming cells were scored as positive.
Calculations to determine the frequency of B cells secreting IgA were based on Possion distribution analysis [26] . The frequency of negative responses at each input number of B cells was used to construct a plot of the log 10 of the percentage of negative cultures verses the numbers of cultured B cells. Possion distribution laws predict a straight line that extrapolates to 100% negative responses in cultures with no IgA-secreting B cells. The frequency of IgA-secreting B cells was derived graphically, as demonstrated in the figure, by interpolating to the cell number at which 37% of cultures were negative. This yields a cell number at which, on average, there is one IgA-secreting clone/culture.
The average size of IgA-secreting clones was calculated using the input number of B cells at which 37% of the cultures were negative. At this input number, the positive cultures contained an average of one precursor/culture. Clone sizes are expressed as the average number of IgA-secreting cells, as assessed by the ELISPOT assay, in a clone, resulting from one precursor on Day 6 of culture.
RNA preparation and RT-PCR
RNA preparation, reverse transcription, and PCR were performed as described previously [25] . PCR primers were synthesized by Bioneer (Seoul, Korea): GLT ␣ sense, 5=-CAA GAA GGA GAA GGT GAT TCA G-3=, and antisense, 5=-GAG CTG GTG GGA GTG TCA GTG-3=; GLT ␥1 sense, 5=-CAG CC T GGT G TC AAC TAG-3=, and antisense, 5=-CTG TAC ATA TGC AAG GCT-3=; GLT ␥2a sense, 5=-GCT GAT GTA CCT ACC TGA GAG A-3=, and antisense, 5=-GCT GGG CCA GGT GCT CGA GGT T-3=; GLT ␥2b sense, 5=-GGG AGA GCA CTG GGC CTT-3=, and antisense, 5=-AGT CAC TGA CTC AGG GAA-3=; GLT ␥3 sense, 5=-CAA GTG GAT CTG AAC ACA-3=, and antisense, 5=-GGC TCC ATA GTT CCA TT-3=; GLT ⑀ sense, 5=-ACT AGA GAT TCA CAA CG-3=, and antisense, 5=-AGC GAT GAA TGG AGT AGC-3=; PST ␣ sense, 5=-GAG CTG GTG GGA GTG TCA GTG-3=, and antisense, 5=-CTC TGG CCC TGC TTA TTG TTG-3=; TGF-␤1 sense, 5=-CTG CTC CAC CTT GGG CTT GCG ACC CAC-3=, and antisense, 5=-CGG GGC GAC CTG GGC ACC ATC CAT GAC-3=; AID sense, 5=-TGC TAC GTG GTG AAG AGG AG-3=, and antisense, 5=-TCC CAG TCT GAG ATG TAG CG-3=; ␤-actin sense, 5=-CATGT TTGAG ACCTT CAACA CCCC-3=, and antisense, 5=-GCCAT CTCCT GCTCG AAGTC TAG-3=. All reagents for RT-PCR were purchased from Promega. PCR reactions for ␤-actin were performed in parallel to normalize cDNA concentrations within each set of samples. Aliquots of the PCR products were resolved by electrophoresis on 2% agarose gels. 
Labeling with CFSE and flow cytometric analysis
Statistical analysis
Statistical differences between experimental groups were determined by ANOVA, and values of P Ͻ 0.05 by unpaired, two-tailed Student's t-test were considered significant.
RESULTS
Effects of RA and TGF-␤1 on Ig secretion by spleen B cells
The regulatory role of RA in IgA expression by murine B cells has not been defined specifically. It has been shown that RA up-regulates IgA secretion but only noticeably in the presence of IL-5, IL-6, or both together [14, 27] . Our group and others demonstrated that TGF-␤1 promotes IgA and IgG2b isotype switching in mice [5, 22, 28 -30] . The RA-stimulated IgA response has been shown to be partially mediated via induction of active TGF-␤ [19, 20] . The exact role of RA in IgA isotype switching is not elucidated yet, particularly its association with the action of TGF-␤. Thus, we first measured Ig secretions by mouse spleen B cells under the influence of RA and TGF-␤1. Although RA (25 nM) alone is far less potent than TGF-␤1 (0.2 ng/ml), it enhanced IgA secretion significantly (Fig. 1A) .
In contrast, RA decreased IgM and IgG1 secretion substantially, including IgG2b (Supplemental Fig. 1 ). Consequently, RA increased only IgA secretion; this property of RA is in contrast to that of TGF-␤1, which increased IgA and IgG2b secretion. The combination of RA and TGF-␤1 did not result in enhancement of IgA secretion (Fig. 1A) . IgA induction by a combination of the two reagents was lower than the effect attained by either one. Given that RA possesses antiproliferative activity [31, 32] , similar to that of TGF-␤1, we postulated that the combination of RA (25 nM) and TGF-␤1 (0.2 ng/ml) would be too suppressive for cells, resulting in diminished IgA secretion. We have demonstrated previously that the IgA-enhancing activity of TGF-␤1 is related, in part, to its ability to inhibit cell growth [8] . Therefore, it was necessary to determine the effects of RA and TGF-␤1 on cell growth and proliferation. Each concentration of RA and TGF-␤1 that increased IgA secretion inhibited cell growth (Fig. 1B) and cell proliferation (Fig. 1C , left panel). RA plus TGF-␤1 almost entirely ablated cell proliferation (Fig. 1C , left panel) and cell growth (Fig. 1B) . These results clearly show that the combination of RA and TGF-␤1 causes B cell-growth suppression, excessively leading to decreased IgA production, although the antiproliferative activity of each factor can contribute to IgA expression on its own. Under the same conditions, overall cell proliferation was enhanced substantially by IL-5, a well-known B cell growth supporting cytokine ( 
Effect of transient exposure of RA on IgA production
We assumed that the unfavorable aspect of RA in IgA expression was abolished by transient exposure of RA to B cells. Given that the IgA isotype-switching event during B cell differentiation is known to occur ϳ2 days following antigen stimulation, we reasoned that RA exposure for 2 days would be sufficient for IgA production if the major function of RA is to cause IgA isotype switching. LPS-stimulated whole-spleen B cells were exposed to RA (25 nM) and/or TGF-␤1 (0.2 ng/ml) for 2 days, washed, and changed to media containing LPS without the two reagents. RA alone increased IgA secretion by threefold (Supplemental Fig. 2) . Furthermore, when the culture media were changed, the repression of IgA secretion by the combination of RA and TGF-␤1 disappeared, although an (5 nM) and TGF-␤1 (0.05 ng/ml). After 2 days of culture, cells were washed with incomplete media, and the cultured media were changed to RA-and TGF-␤1-free media. After an additional 5 days of culture, supernatants were collected, and Ig production was determined by isotype-specific ELISA. (B) Pretreatment of RA with anti-TGF-␤ antibody before cell culture. RA (5 nM) and TGF-␤1 (0.05 ng/ml) were pretreated with anti-pan TGF-␤ antibody (5 g/ml) for 1 h. These reagents were added to LPS-activated spleen B cells, and the media were changed as described in A. (C) LPS-activated sIgA Ϫ spleen B cells were cultured with RA and TGF-␤1 in the presence or absence of antipan TGF-␤ antibody (5 g/ml). Culture conditions were the same as in A. Data are means of triplicate samples Ϯ sem. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. additional increase was not observed. Under the same conditions, IL-5 enhanced overall IgA production, especially RAinduced IgA production. Similar patterns of IgA secretion were observed when lower concentrations of RA (5 nM) and TGF-␤1 (0.05 ng/ml) were adopted (Supplemental Fig. 2) . Interestingly, RA and TGF-␤1, in combination, noticeably increased IgA secretion, and the level was higher than that caused by each treatment alone. This was not the case for other Ig isotypes (IgG2b, IgG2a, IgG1, and IgG3; Supplemental Fig. 2) . Together, these results suggest that RA by itself can stimulate B cells to cause IgA CSR and that its resultant, antiproliferative activity is detrimental to IgA secretion. Our data reveal that IL-5 is not a prerequisite for the induction of the IgA response by RA. To further characterize the B cell phenotype targeted by RA, sIgA Ϫ spleen B cells were cultured in the presence of low concentrations of RA and TGF-␤1, and they were removed after the first 2 days of culture ( Fig. 2A) . Overall, IgA production patterns by sIgA Ϫ B cells were the same as those by whole B cells. The increasing effects of RA plus TGF-␤1 on IgA production were more dramatic in the culture of the sIgA Ϫ B cell population.
IgA-promoting activity of RA is not associated with action of TGF-␤ As an extremely small amount of TGF-␤ (50 pg/ml) increased IgA production, we wanted to ensure that there was no contamination of our RA stock. We pretreated RA with anti-pan TGF-␤ antibody before adding the RA to the culture. As shown in Fig. 2B , the increase of IgA by RA was not affected by pretreatment of anti-pan TGF-␤ antibody, whereas the increase of IgA by TGF-␤1 was abrogated completely by such pretreatment, indicating that RA was not contaminated with TGF-␤. It has been demonstrated that RA modulates B cells to secrete TGF-␤1, which in turn, can participate in IgA production [20] .
To explore this possibility, anti-pan TGF-␤ antibody was added to B cell cultures. The increase of IgA by RA was not affected by anti-pan TGF-␤ antibody (Fig. 2C) , implicating that RA does not cause the cultured B cells to produce any significant amount of TGF-␤. In addition, neither levels of TGF-␤1 mRNA nor secreting TGF-␤ are elevated in the RA-stimulated B cells (Supplemental Fig. 3 ). Together, these results suggest that RA directly stimulates B cells to express IgA, without any link to TGF-␤.
RA increases IgA isotype switching at the clonal level
As RA directly modulates B cells to differentiate into IgA B cells, it was necessary to investigate if RA increased IgA production by increasing the total number of cells that secrete IgA or simply by increasing the amount of IgA secreted/cell. As shown in Fig. 3A , there was an increase in the number of IgA-secreting cells in RA-or TGF-␤1-stimulated cultures and a further increase in the cultures stimulated with RA plus TGF-␤1 at the low and high concentrations. This was paralleled by an increase in the total amount of IgA secreted (Fig.  3A) . We subsequently performed a limiting dilution analysis to distinguish whether increases in the number of IgA-secreting cells in the above experiments are a result of: (1) an increase in the frequency of B cells that switch to express the IgA isotype after stimulation with RA or (2) increased proliferation of B cells that are already committed to express the IgA isotype. sIgA Ϫ spleen B cells were cultured in limiting dilution with RA in parallel with TGF-␤1, as reported previously [8] . As shown in Fig. 3B , RA stimulated an approximate twofold increase in the frequency of IgA-secreting B cell clones among populations of LPS-activated sIgA Ϫ B cells without increasing the number of IgA-secreting B cells/clone. This action of RA was quite similar to that of TGF-␤1 in our prior study [8] . These data document the activity of RA as an IgA switch factor.
RA specifically increases IgA CSR through RAR
Transcription of the unrearranged C ␣ gene to produce GLT ␣ precedes CSR to IgA (Fig. 4A) [33] . Thus, TGF-␤1 induces GLT ␣ transcription and subsequent CSR to IgA [34] . Once IgA CSR occurs, PST ␣ and CT ␣ are also expressed [2, 35, 36] . Therefore, expression of PST ␣ , CT ␣ , and GLT ␣ can be used to indicate active IgA CSR. As RA increased IgA isotype switching at the clonal level, it was necessary to determine whether RA has such an effect at the molecular level. Expression of GLT ␣ , PST ␣ , and CT ␣ was enhanced by RA or TGF-␤1 and enhanced further by RA and TGF-␤1 in combination (Fig. 4B ). This was paralleled by an increase in IgA secretion, when RA and TGF-␤1 were transiently exposed ( Fig. 2A) . In contrast, RA decreased the expression of other GLTs (GLT ␥1 , GLT ␥2b , and GLT ␥2a ), and TGF-␤1 slightly increased GLT ␥2b expression. On the other hand, RA did not enhance the expression of AID, an essential enzyme for Ig CSR (Supplemental Fig. 4) . These results indicate that RA induces IgA CSR more specifically than TGF-␤1.
To verify the specific activity of RA used in this study, AM80 (a RAR agonist) and LE540 (a RAR antagonist) were tested along with RA. As shown in Fig. 5 , AM80 increased IgA secretion to the level incited by RA, whereas LE540 abrogated the increase of IgA and GLT ␣ by RA. These results suggest that RA induces IgA CSR primarily through RAR.
RA enhances IgA production in vivo
To determine the role of RA in Ig production in vivo, RA was administered into mice perorally, and Ig synthesis was measured by ELISA. The amount of IgA in the fecal pellet was increased by perorally delivered RA, with no significant changes in the level of serum IgA (Fig. 6A) . Similarly, IgA plasma cells (B220 Ϫ IgA ϩ ) were increased by RA in LP but not in spleen (Fig. 6B) . Accordingly, IgA production by PP and MLN B cell cultures, but not spleen B cell cultures, was augmented substantially by RA (Fig. 6C) . In addition, GLT ␣ expression was also notably enhanced in PP cells from RA-treated mice (Supplemental Fig. 5 ). These results suggest that PP and MLN B cells are involved in an increase of intestinal IgA production when RA is delivered perorally. In addition, we found that fecal IgA levels in VAD mice were far lower than those in control mice (Fig. 6D) . Moreover, the decreased fecal IgA level of the VAD mice was restored by peroral and i.p. delivery of RA (Fig. 6E) , suggesting that RA is physiologically relevant to mucosal IgA synthesis.
We also determined the effect of RA in the mice administered i.p. Similar to that seen in the mice administered per- orally, the amount of IgA in the fecal pellet was much greater than that from control mice (Supplemental Fig. 6 ). In contrast, although absolute amounts were far less than IgA, the amounts of IgG1 and IgM in fecal pellets were decreased dramatically by administration of RA. Similar to in fecal pellets, serum IgA was increased via administration of RA, whereas serum IgM, IgG1, and IgG2b were decreased. To obtain information on how intestinal and serum IgA is increased by RA, IgA responses were determined in MLN, PP, and spleen B cells. Under the influence of RA, IgA production was increased in the MLN and spleen B cell cultures but barely affected in the PP B cell culture (Supplemental Fig. 6 ). GLT ␣ expression was also enhanced in LPS-spleen B cells from RAadministered mice (Supplemental Fig. 7) . These results suggest that once RA is administered i.p., the enhancement of intestinal IgA and serum IgA is attributed to the involvement of MLN and spleen B cells, respectively.
Effects of RA and TGF-␤1 on expression of guthoming receptors and differentiation into plasma cells
Thus far, our results show clearly that RA has a specific activity for IgA isotype switching and that RA can synergize with TGF-␤1 to enhance IgA production. To produce mucosal IgA efficiently in vivo, B cells must be located to the corresponding mucosal tissues. In addition to the up-regulation of IgA production, RA is known to induce gut-tropic IgA B cells [14] . We explored how RA-induced gut-homing receptors are expressed under the influence of TGF-␤1. Expression of guthoming receptors CCR9 and ␣4␤7 was enhanced substantially, not only RA but also by TGF-␤1 and enhanced further by RA and TGF-␤1 in combination ( Fig. 7A and B) . The same was true for the expression of CD138, a plasma cell marker (Fig.  7C ). This was paralleled by increases in the expression of GLT ␣ and the total amount of IgA secreted ( Fig. 7D and E) . These results indicate that the combination of RA and TGF-␤1
stimulates B cells to commit IgA CSR, express gut-homing receptors, and differentiate into IgA plasma cells, leading to the production of IgA antibody in the gut.
DISCUSSION
Our data indicate that RA has a specific activity of IgA isotype switching. Importantly, this activity of RA is more selective than that of TGF-␤1, a well-known switching factor for mouse IgA and IgG2b [5, 22, 28, 29] . Although TGF-␤1 is regarded as a physiological mediator of IgA isotype switching [10] , it is not still clearly understood why only the IgA isotype is predominant in the mucosal tissues. We have shown previously that PP CD4 ϩ T cell-derived IL-21 inhibits TGF-␤1-induced IgG2b production [11] . Coincidentally, others have demonstrated that follicular B Th cells derived from Foxp3 ϩ T cells secrete IL-21 in PP [12] . It is plausible that IL-21 has an important effect on selective IgA ϩ B cell commitment in PP. Nevertheless, there is no direct evidence that the combination of TGF-␤1 with IL-21 is primarily responsible for maintaining IgA antibody predominance in mucosal tissues. In this context, it is noteworthy that RA alone specifically increases IgA CSR. This is physiologically relevant, as our in vivo data suggest that the availability of RA in mice is well-correlated with the level of mucosal IgA antibody ( Fig. 6 and Supplemental Fig. 6 ). Similar observations have also been made by others [14, 37] . As for human B cells, RA also increased IgA secretion by human tonsil B cells that were activated with anti-CD40 antibody, anti-IgM antibody, and IL-4 (unpublished data).
We found that RA has pro-and contra-effects on IgA isotype expression. RA clearly induced IgA CSR based on the increase of GLT ␣ expression and IgA clonal frequency (pro). In contrast, after inducing IgA CSR, RA caused detrimental effects on switched B cells by excessive antiproliferative activity, leading to the decline of IgA production (contra). The present study clearly showed that addition of IL-5 lessens the antipro- liferative activity of RA, leading to IgA production. We subsequently found that IL-5 is not absolutely required for RA-induced IgA production in vitro. Thus, transient exposure to small amounts of RA for the first 2 days also markedly enhanced IgA production, similar to that induced by the addition of IL-5. This most likely explains why others have claimed that additional IL-5 is required for the RA-induced IgA response [14, 20, 27] . We believe that it is quite clear that RA by itself has activity regulating IgA production, and the exposure dose, duration, and timing of RA administration are critical. IL-5 could act as a B cell growth factor in a RA-mediated mucosal IgA response in vivo, although this needs more study. Of note, the synergistic effect of RA and TGF-␤1 on sIgA expression has been demonstrated but only in the presence of IL-5 [38] . We, however, observed that in the absence of IL-5, RA and TGF-␤ synergized to increase IgA production. This was paralleled by an increase of IgA CSR based on the expression of GLT ␣ , PST ␣ , and CT ␣ (Fig. 4) . Herein, the combined effect of the two mediators was not seen in IgG2b production. Rather, RA diminished the TGF-␤-mediated IgG2b response. These results indicate that RA, in combination with TGF-␤, specifically induces IgA CSR, leading to promotion of the IgA response. The activity of RA and TGF-␤ in the IgA response is analogous to their activity in the development of Tregs induced extrathymically. It has been well-catalogued that RA and TGF-␤ enhance the peripheral conversion of naive CD4 ϩ T cells into Foxp3 ϩ Tregs [15] [16] [17] [18] 39] . Inducible Tregs are known to locate primarily in GALT. This is believed to be because GALT-DCs, such as MLN-and LP-DCs, favorably provide RA to CD4 ϩ T cells [15, 16] . Similarly, RA derived from GALT-DCs is also critical for the mucosal IgA response [14, 40 -42] . It is conceivable that in GALT, RA and TGF-␤ are not only key mediators in Treg conversion but also in intestinal IgA response.
Another important activity of GALT-DC-derived RA is to induce gut-homing receptors CCR9 and ␣4␤7 on T and B cells [13, 14, 37, 42, 43] . The findings in the present study extend these observations. RA, in the presence of TGF-␤1, was much more potent than RA alone in the expression of gut-homing receptors and CD138, suggesting that TGF-␤1, in cooperation with RA, plays an important role in gut-homing of IgA plasma cells, similar to the events of IgA CSR and inducible Treg dif- ferentiation. Consistent with our results, it has been demonstrated recently that the combination of RA and TGF-␤1 enhances the expression of ␣4/␤7 integrin on T cells [44] . It remains to be determined if TGF-␤1, like RA, is physiologically relevant to gut-homing of IgA plasma cells.
RA is well known to transduce its signal, mostly through binding to a heterodimer of nuclear receptors, RARs, and retinoid X receptors [45, 46] . These two receptors occupy a specific sequence of a target gene promoter, PuG(G/T)TCA, termed the RARE [46] . As expected, our data indicate that RA induces IgA CSR via RAR (Fig. 5) , and RAR is also known to mediate RA-induced CCR9 and Foxp3 expression on T cells [39, 47] . We found that the single putative RARE (ϩ4TGACCCϩ9) within the GL␣ promoter is dispensable for RA-induced GL␣ promoter activity, as under the influence of RA, the putative RARE-mutated promoter activity was comparable with that of WT (Supplemental Fig. 8 ). This raised the question of how RAR mediates RA-induced GL␣ transcription without directly binding to RARE. We do note that the present study does not address the specific mechanisms by which RA induces IgA CSR through RAR. In this regard, there are reports that RA enhances expression and phosphorylation of Smad3 [39, 48] , and RAR can interact with Smad3 in the cytoplasm [49] , suggesting that RAR may crosstalk, at least partially, with the TGF-␤ signaling pathway toward RA-induced IgA CSR. In addition, it has been shown that the expression of RAR can be increased by TGF-␤ signaling [50] . These results suggest that RA and TGF-␤ could cooperatively augment their mutual signaling to further enhance IgA CSR, although the detailed, underlying mechanism remains to be determined.
The immune system of newborns is functionally immature and enters a state of extensive differentiation in the early postnatal period. Various cytokines present in maternal milk affect the maturation of the infant's immune system [51] . Vitamin A and TGF-␤ are abundant in colostrum and milk [52, 53] . Thus, our findings, which demonstrate an increased IgA classswitching and expression of gut-homing molecules (CCR9 and ␣4␤7) on IgA plasma cells by RA (a vitamin A metabolite), in cooperation with TGF-␤, suggest that these molecules are important in the establishment of intestinal IgA humoral immunity in newborns, as well as in postweaning life. As RA and TGF-␤ also promote differentiation of Tregs in the gut, it is highly plausible that these two molecules-RA as an exogenous source and TGF-␤ as an endogenous source-play pivotal roles in maintaining mucosal homeostasis. AUTHORSHIP G-Y.S., Y-S.J., H-A.K., M-R.L., M-H.P., and J-M.L. performed all of the experiments and analyzed the data. S-R.P. and J.C. discussed and reviewed the manuscript. P-H.K. developed the hypothesis, designed the experiments, and wrote the paper with assistance from G-Y.S. and Y-S.J.
